These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19373520)

  • 1. Current status and issues of C1q nephropathy.
    Mii A; Shimizu A; Masuda Y; Fujita E; Aki K; Ishizaki M; Sato S; Griesemer A; Fukuda Y
    Clin Exp Nephrol; 2009 Aug; 13(4):263-274. PubMed ID: 19373520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular deposition of mannose-binding lectin in human glomerulonephritis.
    Lhotta K; Würzner R; König P
    Nephrol Dial Transplant; 1999 Apr; 14(4):881-6. PubMed ID: 10328463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.
    Jennette JC; Hipp CG
    Am J Kidney Dis; 1985 Aug; 6(2):103-10. PubMed ID: 3875286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis.
    Srivastava T; Chadha V; Taboada EM; Alon US
    Pediatr Nephrol; 2000 Sep; 14(10-11):976-9. PubMed ID: 10975310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic significance of glomerular C1q deposits in primary MN.
    Zhang MF; Cui Z; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Liu G; Zhao MH
    Clin Chim Acta; 2018 Oct; 485():152-157. PubMed ID: 29969623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous improvement in a case of C1q nephropathy.
    Nishida M; Kawakatsu H; Komatsu H; Ishiwari K; Tamai M; Sawada T
    Am J Kidney Dis; 2000 May; 35(5):E22. PubMed ID: 10793051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.
    Jennette JC; Hipp CG
    Am J Clin Pathol; 1985 Apr; 83(4):415-20. PubMed ID: 3885712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG nephropathy - confusion and overlap with C1q nephropathy.
    Lim BJ; Hong SW; Jeong HJ
    Clin Nephrol; 2009 Nov; 72(5):360-5. PubMed ID: 19863878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q nephropathy presenting as acute renal failure.
    Malleshappa P; Ranganath R; Chaudhari AP; Ayiangar A; Lohitaksha S
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):324-6. PubMed ID: 21422635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis.
    Mannik M; Wener MH
    Arthritis Rheum; 1997 Aug; 40(8):1504-11. PubMed ID: 9259432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Pathological and clinical observation in five patients.
    Jones E; Magil A
    Am J Clin Pathol; 1982 Jul; 78(1):29-34. PubMed ID: 7048894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
    Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q nephropathy with acute hemolytic uremic syndrome.
    Kanodia KV; Vanikar AV; Shah PR; Kute VB; Feroz A; Suthar K; Trivedi HL
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):556-8. PubMed ID: 22569444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q nephropathy in India: a single-center study.
    Kanodia KV; Vanikar AV; Patel RD; Suthar KS; Patel HV; Gumber MA; Shah PR; Trivedi HL
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):398-403. PubMed ID: 25758901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q Nephropathy: The Unique Underrecognized Pathological Entity.
    Devasahayam J; Erode-Singaravelu G; Bhat Z; Oliver T; Chandran A; Zeng X; Dakshinesh P; Pillai U
    Anal Cell Pathol (Amst); 2015; 2015():490413. PubMed ID: 26640759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies.
    Trouw LA; Seelen MA; Duijs JM; Benediktsson H; Van Kooten C; Daha MR
    Clin Exp Immunol; 2003 Apr; 132(1):32-9. PubMed ID: 12653833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing C1q nephropathy from lupus nephritis.
    Sharman A; Furness P; Feehally J
    Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
    Hsu HC; Chen WY; Lin GJ; Chen L; Kao SL; Huang CC; Lin CY
    Histopathology; 1984 May; 8(3):435-46. PubMed ID: 6376323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q nephropathy in the pediatric population: pathology and pathogenesis.
    Wenderfer SE; Swinford RD; Braun MC
    Pediatr Nephrol; 2010 Aug; 25(8):1385-96. PubMed ID: 20180137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.